Drug intelligence / Profile preview

L-742001

Development stage
Discontinued
Lead developer
Merck
Modality
Small Molecules
01

Overview

L-742001 is a synthetic small-molecule diketo acid inhibitor of the influenza A virus PA endonuclease, an essential metal-dependent endonuclease subdomain of the viral RNA-dependent RNA polymerase complex that mediates “cap-snatching” from host pre-mRNAs to prime viral mRNA synthesis.[3][4][6][8] By chelating the two-metal catalytic core and engaging multiple residues within the PA endonuclease active site, L-742001 potently inhibits endonuclease activity (IC50 ~0.5 μM) and reduces influenza A viral replication in cell culture and in mouse models, establishing this chemotype as a prototype scaffold for influenza endonuclease-targeted antivirals.[3][4][6][8] Originally discovered in the 1990s and reported by Merck as an early RNA polymerase/PA inhibitor lead, L-742001 showed strong antiviral activity but was ultimately deemed unsuitable for further clinical development; however, its structural and resistance profiles have been widely used to map PA active-site interactions and guide the design of newer influenza endonuclease inhibitors.[3][6][8][9]

Other names
L-742001 hydrochlorideL742001 hydrochlorideL 742001 hydrochloride
02

Targets

CEN (Influenza A virus (2009 H1N1) polymerase acidic protein (PA) endonuclease)

Beyond the preview

Go deeper on L-742001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-742001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call